KLK3 and pachyonychia congenita: Several prognostic nomograms based on clinical variables, e.g., Gleason Grade, tumor stage and serum prostate specific antigen (PSA), have been developed in an attempt to stratify localized PC (LPC) patients into low, intermediate or high-risk groups2,3.